Abstract

Purpose of Review: In the USA, around 30% of 795,000 strokes per year are due to proximal large-vessel occlusion, and these are a major cause of death and disability. We review the most recent advances regarding treatment of ischemic stroke amenable to mechanical thrombectomy. Recent Findings: In the last four years, clinical trial evidence has expanded the time window for successful endovascular treatment to 24 h. Current research is aimed at expanding patient selection to mild strokes, large ischemic cores and occlusions of smaller, more distal blood vessels. Further, we have developed understanding of how to manage blood pressure after thrombectomy and even had promising results for a neuroprotective agent in these patients. Summary: Thrombectomy has transformed the treatment of ischemic stroke due to large-vessel occlusion. Recent research has focused on expanding patient candidacy for endovascular treatment and improving medical management to support better neurologic outcomes.

Original languageEnglish
Pages (from-to)83-91
Number of pages9
JournalCurrent neurology and neuroscience reports
Volume22
Issue number1
DOIs
StatePublished - Jan 2022

Keywords

  • Large-vessel occlusion
  • Stroke
  • Thrombectomy

Fingerprint

Dive into the research topics of 'Endovascular Treatment of Acute Stroke'. Together they form a unique fingerprint.

Cite this